AIM ImmunoTech
13 hedge funds and large institutions have $4.1M invested in AIM ImmunoTech in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
7% less funds holding
Funds holding: 14 → 13 (-1)
11% less capital invested
Capital invested by funds: $4.63M → $4.1M (-$530K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$74.6K |
| 2 |
Morgan Stanley
New York
|
+$59.7K |
| 3 |
Renaissance Technologies
New York
|
+$59.7K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$44.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$44.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$21K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$14.9K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10K |
| 5 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PSC
26
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$9K | -1 | Closed |
|
27
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | – | – |
|
AIM Hedge Fund Activity: Q4 2014 in Review
13 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2014, worth a combined $4.1M — down 11% from $4.63M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AIM and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $74.6K. The largest seller was Dimensional Fund Advisors, cutting an estimated $44.8K.
- 13 institutional investors held AIM ImmunoTech (AIM) as of Q4 2014, down from 14 in Q3 2014.
- Funds reported $4.1M of AIM ImmunoTech stock for Q4 2014, down 11% quarter-over-quarter.
- 2 funds opened new AIM ImmunoTech positions in Q4 2014 and 3 closed out, a net change of -1 holder.
- The largest AIM ImmunoTech buyer in Q4 2014 was Virtu KCG Holdings, an estimated $74.6K added.
- The largest AIM ImmunoTech seller in Q4 2014 was Dimensional Fund Advisors, an estimated $44.8K sold.
Based on aggregated 13F filings for Q4 2014.